Application in Particular Diseases
ChemicalBook > CAS DataBase List > Teriparatide acetate

Teriparatide acetate

Application in Particular Diseases
Product Name
Teriparatide acetate
CAS No.
52232-67-4
Chemical Name
Teriparatide acetate
Synonyms
Parathar;hPTH (1-34);Teriparatid;Teroparatide;CNV-38d(1-34);Teriparatide CRS;PTH (HUMAN, 1-34);Teriparatida(net);PTH (1-34) (HUMAN);Parathormone (1-34)
CBNumber
CB2284468
Molecular Formula
C172H278N52O47S2
Formula Weight
3890.49792
MOL File
52232-67-4.mol
More
Less

Teriparatide acetate Property

Melting point:
>205oC (dec.)
RTECS 
SQ7770000
storage temp. 
−20°C
solubility 
DMSO (Slightly), Water (Slightly)
form 
powder
color 
White to Off-White
Water Solubility 
Soluble to 0.40 mg/ml in water
Sequence
H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH
Stability:
Hygroscopic
CAS DataBase Reference
52232-67-4(CAS DataBase Reference)
More
Less

Safety

WGK Germany 
3
HS Code 
2937190000
Hazardous Substances Data
52232-67-4(Hazardous Substances Data)
More
Less

Hazard and Precautionary Statements (GHS)

Symbol(GHS)
Signal word
Warning
Hazard statements

H227Combustible liquid

H302Harmful if swallowed

Precautionary statements

P210Keep away from heat/sparks/open flames/hot surfaces. — No smoking.

P264Wash hands thoroughly after handling.

P264Wash skin thouroughly after handling.

P270Do not eat, drink or smoke when using this product.

P280Wear protective gloves/protective clothing/eye protection/face protection.

P301+P312IF SWALLOWED: call a POISON CENTER or doctor/physician IF you feel unwell.

P330Rinse mouth.

P370+P378In case of fire: Use … for extinction.

P403+P235Store in a well-ventilated place. Keep cool.

P501Dispose of contents/container to..…

More
Less

N-Bromosuccinimide Price

Sigma-Aldrich
Product number
Y0001916
Product name
Teriparatide
Purity
European Pharmacopoeia (EP) Reference Standard
Packaging
Y0001916
Price
$201
Updated
2024/03/01
Sigma-Aldrich
Product number
P3796
Product name
Parathyroid Hormone Fragment 1-34 human
Purity
≥95% (HPLC), powder
Packaging
0.1mg
Price
$178
Updated
2024/03/01
Sigma-Aldrich
Product number
P3796
Product name
Parathyroid Hormone Fragment 1-34 human
Purity
≥95% (HPLC), powder
Packaging
0.5mg
Price
$271
Updated
2024/03/01
Sigma-Aldrich
Product number
1643962
Product name
Parathyroid Hormone Fragment 1-34 human
Packaging
1mg
Price
$1530
Updated
2024/03/01
Sigma-Aldrich
Product number
05-23-5501
Product name
Parathyroid Hormone 1-34, Human - CAS 52232-67-4 - Calbiochem
Purity
N-terminal active peptide fragment of the native hormone that functions as a regulatory factor in the homeostatic control of Ca2+ and phosphate metabolism.
Packaging
1mg
Price
$433
Updated
2024/03/01
More
Less

Teriparatide acetate Chemical Properties,Usage,Production

Application in Particular Diseases

In Osteoporosis:

  • Teriparatide is a recombinant product representing the first 34 amino acids in human parathyroid hormone. Teriparatide increases bone formation, the bone remodeling rate, and osteoblast number and activity. Both bone mass and architecture are improved.
  • Teriparatide is FDA approved for postmenopausal women and men who are at high risk for fracture. Candidates for therapy include patients with a history of osteoporotic fracture, multiple risk factors for fracture, very low bone density (e.g., T-score <–3.5), or those who have failed or are intolerant of previous bisphosphonate therapy.
  • The drug reduces fracture risk in postmenopausal women, but no fracture data are available in men. Lumbar spine BMD increases are higher than with any other osteoporosis therapy. Although wrist BMD is decreased, wrist fractures are not increased.
  • Discontinuation of therapy results in a decrease in BMD, but some antifracture efficacy appears to be maintained. Sequential therapy with teriparatide followed by an antiresorptive agent (e.g., bisphosphonate) should be considered to maintain BMD gains.
  • The dose is 20 mcg administered subcutaneously in the thigh or abdominal area (see Table 3-4). The initial dose should be given with the patient either lying or sitting, in case orthostatic hypotension occurs. Each prefilled 3-mL pen device delivers a 20-mcg dose each day for up to 28 days; the pen device should be kept refrigerated.
  • Transient hypercalcemia rarely occurs. A trough serum calcium concentration is recommended 1 month after initiation of therapy.
  • Teriparatide is contraindicated in patients at baseline increased risk for osteosarcoma (e.g., Paget’s bone disease, unexplained alkaline phosphatase elevations, pediatric patients, young adults with open epiphyses, or patients with prior radiation therapy involving the skeleton).

Description

The anabolic drug teriparatide acetate (TA), known as recombinant human parathyroid hormone 1–34, which directly promotes bone formation by generating new osteocytes, has been introduced as a novel therapeutic agent for osteoporosis. Distinct from antiresorptive drug treatment, patients with osteonecrosis of the jaw showed successful clinical outcomes after weekly administration of TA. In addition, adverse outcomes of long-term bisphosphonate treatment, such as bone fracture, were healed after usage of TA, and better bone mass and mineral density improvements at the lumbar spine and femoral neck were achieved with TA treatment than with bisphosphonate treatment[1].

Uses

A fragment of human parathyroid hormone (hPTH) peptide sequence containing the 34 N-terminal residues of hPTH. This fragment was also found to be an agonist at PTH1 and PTH2 receptors.

General Description

Teriparatide is a recombinantform of parathyroid hormone, which is used for the treatmentof osteoporosis in men and postmenopausal women.The N-terminal region possesses 34 amino acids, which areidentical to the biologically active region of the 84-aminoacid sequence of human parathyroid hormone. It has beenshown to act on osteoblasts to stimulate new bone growthand improve bone density.

Biological Activity

parathyroid hormone (1-34) (human), (c181h291n55o51s2), a peptide with the sequence h2n-svseiqlmhnlgkhlnsmervewlrkklqdvhnf-oh, mw= 4117.72. parathyroid hormone (pth), parathormone or parathyrin, is secreted by the chief cells of the parathyroid glands as a polypeptide containing 84 amino acids. it acts to increase the concentration of calcium (ca2+) in the blood, whereas calcitonin (a hormone produced by the parafollicular cells (c cells) of the thyroid gland) acts to decrease calcium concentration. pth acts to increase the concentration of calcium in the blood by acting upon the parathyroid hormone 1 receptor and the parathyroid hormone 2 receptor(1). parathyroid hormone regulates serum calcium, it enhances the release of calcium from the large reservoir contained in the bones(2). it enhances active reabsorption of calcium and magnesium from distal tubules and the thick ascending limb(3). it enhances the absorption of calcium in the intestine by increasing the production of activated vitamin d.figure1 formula of parathyroid hormone (1-34) (human)figure2 the parathyroid hormone (pth) system

Biochem/physiol Actions

Parathyroid hormone (PTH) is a parathyroid-secreted polypeptide hormone that increases the level of calcium in blood by enhancing calcium mobilization from bone, increasing the calcium:phosphate ratio in the kidney and promoting the absorption of calcium by the intestines. PTH is an anabolic agent that improves osteoblastic bone development. PTH 1-34 induces bone morphogenetic protein (BMP) gene transcription. Active N-terminal fragment of PTH (residues 1–34), has been used as a therapeutic for postmenopausal women with osteoporosis who are at high risk for fracture.

Mechanism of action

Teriparatide acetate is the salt form of teriparatide and has a similar mechanism of action to teriparatide. Teriparatide is a parathyroid hormone (PTH) analogue that regulates calcium and phosphate metabolism in bone and kidney by binding to the PTH type 1 receptor (PTH1R type) via the N-terminal portion. It has the same effect on calcium-phosphorus homeostasis as endogenous PTH (i.e., increases serum calcium and decreases serum phosphorus).

Pharmacokinetics

If administered once daily or intermittently, teriparatide preferentially enhances osteoblastic function,and bone formation occurs. Continuous exposure to endogenous PTH may result in poor skeletal composition because of enhanced osteoclast-mediated bone resorption. After 18 months of treatment, lumbar BMD increased up to 12% in postmenopausal women. After 10 months of treatment, 53% of men had an increase of 5% or greater in spine BMD. The risk for developing new vertebral fractures was reduced by 65% after 21 months of treatment, and the number of nonvertebral fragility fractures was reduced by 53%.

Clinical Use

In 2002, the U.S. FDA approved teriparatide for the treatment of postmenopausal osteoporosis in patients who have a high risk of fracture as well as to increase bone mass in men with primary or hypogonadal osteoporosis who have a high risk of fracture. Teriparatide is recombinant human PTH 1-34, the biologically active portion of the endogenously produced preprohormone. Unlike the bisphosphonates, which are classified as bone restorative agents, teriparatide is the first approved bone-forming agent. Bone formation is possible because of the ability of this agent to increase the number of osteoblasts. Although teriparatide enhances the function of both osteoclasts and osteoblasts, the exposure incidence dictates its effect on the skeleton.

Side effects

Temporary increases in serum calcium levels occur following administration of teriparatide. As a result, this agent is contraindicated in patients who are predisposed to hypercalcemia. Some evidence suggests that these elevations in serum calcium levels may cause a patient who is taking digitalis to experience digitalis toxicity (39). Teriparatide should not be prescribed to patients with Paget's disease, children, young adults, women who are pregnant or nursing, and those patients who have received skeletal radiation therapy. Because of an increased incidence of osteosarcoma (malignant bone tumors) observed in rats, teriparatide also carries a black box warning

storage

Store at -20°C

Dosage

Teriparatide acetate requires subcutaneous injection into the thigh or abdominal wall, and the recommended dose is 20 mcg once daily. If symptoms of orthostatic hypotension occur, it is administered while the patient is sitting or lying down. It is not recommended to use the drug for more than 2 years in the lifetime of the patient. Use teriparatide injection with caution in patients receiving digoxin. Transient hypercalcemia may predispose patients to digitalis toxicity.

References

[1] Jeeho Sim. “Development of Clinical Weekly-Dose Teriparatide Acetate Encapsulated Dissolving Microneedle Patch for Efficient Treatment of Osteoporosis.” Polymers (2022).

Teriparatide acetate Preparation Products And Raw materials

Raw materials

Preparation Products

More
Less

Teriparatide acetate Suppliers

LGM Pharma
Tel
1-(800)-881-8210
Fax
615-250-9817
Email
inquiries@lgmpharma.com
Country
United States
ProdList
2123
Advantage
70
MedChemexpress LLC
Tel
021-58955995
Fax
609-228-5909
Email
sales@medchemexpress.cn
Country
United States
ProdList
4861
Advantage
58
ApexBio Technology LLC
Tel
+1-832-696-8203
Fax
+1-832-641-3177
Email
info@apexbt.com
Country
United States
ProdList
477
Advantage
60
HBCChem, Inc.
Tel
+1-510-219-6317
Fax
+1-650-486-1361
Email
sales@hbcchem.com
Country
United States
ProdList
10648
Advantage
60
Creative Peptides
Tel
Email
info@creative-peptides.com
Country
United States
ProdList
6083
Advantage
56
Musechem
Tel
+1-800-259-7612
Fax
+1-800-259-7612
Email
info@musechem.com
Country
United States
ProdList
4660
Advantage
60
BOC Sciences
Tel
16314854226; +16314854226
Email
inquiry@bocsci.com
Country
United States
ProdList
19741
Advantage
58
TargetMol Chemicals Inc.
Tel
+1-781-999-5354 +1-00000000000
Email
marketing@targetmol.com
Country
United States
ProdList
32165
Advantage
58
Alchem Pharmtech,Inc.
Tel
8485655694
Email
sales@alchempharmtech.com
Country
United States
ProdList
63687
Advantage
58
TargetMol Chemicals Inc.
Tel
Email
support@targetmol.com
Country
United States
ProdList
38632
Advantage
58
Aladdin Scientific
Tel
+1-+1(833)-552-7181
Email
sales@aladdinsci.com
Country
United States
ProdList
57505
Advantage
58
Protheragen-ING
Tel
+16313385890
Email
info@protheragen-ing.com
Country
United States
ProdList
3868
Advantage
58
United States Biological
Tel
--
Fax
--
Email
sales@advtechind.com
Country
United States
ProdList
6075
Advantage
58
ApexBio Technology
Tel
--
Fax
--
Email
sales@apexbt.com
Country
United States
ProdList
6251
Advantage
58
United States Biological
Tel
--
Fax
--
Email
chemicals@usbio.net
Country
United States
ProdList
6214
Advantage
80
MedChemExpress
Tel
--
Fax
--
Email
sales@medchemexpress.com
Country
United States
ProdList
6398
Advantage
58
Riedel-de Haen AG
Tel
--
Fax
--
Country
United States
ProdList
6773
Advantage
87
Peptides International, Inc.
Tel
--
Fax
--
Email
peptides@pepnet.com
Country
United States
ProdList
555
Advantage
72
Selleck Chemicals LLC
Tel
--
Fax
--
Email
info@selleckchem.com
Country
United States
ProdList
824
Advantage
60
Waterstone Technology, LLC
Tel
--
Fax
--
Email
sales@waterstonetech.com
Country
United States
ProdList
6786
Advantage
30
Accurate Chemical & Scientific Corporation.
Tel
--
Fax
--
Country
United States
ProdList
6747
Advantage
72
AK Scientific, Inc.
Tel
--
Fax
--
Email
sales@aksci.com
Country
United States
ProdList
6347
Advantage
65
The Peptide Laboratory
Tel
--
Fax
--
Email
info@peptidelab.com
Country
United States
ProdList
224
Advantage
30
GenScript Corporation
Tel
--
Fax
--
Email
info@genscript.com
Country
United States
ProdList
400
Advantage
77
Chem-Impex International, Inc.
Tel
--
Fax
--
Country
United States
ProdList
6730
Advantage
64
American Peptide Company
Tel
--
Fax
--
Email
sales@americanpeptide.com
Country
United States
ProdList
1718
Advantage
71
AnaSpec, Inc.
Tel
--
Fax
--
Email
service@anaspec.com
Country
United States
ProdList
4871
Advantage
77
SynPep Corporation
Tel
--
Fax
--
Email
sales@synpep.com
Country
United States
ProdList
1943
Advantage
51
Research Plus, Inc.
Tel
--
Fax
--
Email
respls@aol.com
Country
United States
ProdList
3674
Advantage
51
EMD Biosciences, Inc.
Tel
--
Fax
--
Email
technical@calbiochem.com
Country
United States
ProdList
6529
Advantage
66
More
Less

View Lastest Price from Teriparatide acetate manufacturers

hebei hongtan Biotechnology Co., Ltd
Product
Teriparatide acetate 52232-67-4
Price
US $30.00/box
Min. Order
1box
Purity
99%
Supply Ability
2000kg
Release date
2024-03-20
HEBEI SHENGSUAN CHEMICAL INDUSTRY CO.,LTD
Product
Teriparatide acetate 52232-67-4
Price
US $100.00-75.00/kg
Min. Order
1kg
Purity
99%
Supply Ability
5000Ton
Release date
2024-08-13
Dorne Chemical Technology co. LTD
Product
Teriparatide acetate 52232-67-4
Price
US $1.00/g
Min. Order
1g
Purity
99%
Supply Ability
100kg
Release date
2024-03-26

52232-67-4, Teriparatide acetateRelated Search:


  • PARATHYROID HORMONE HUMAN: FRAGMENT 1-34
  • PARATHYROID HORMONE (HUMAN, 1-34)
  • PARATHYROID HORMONE (1-34), HUMAN
  • PTH (1-34) (HUMAN)
  • PTH (HUMAN, 1-34)
  • Teriparatide acetate
  • SVSEIQLMHNLGKHLNSMERVEWLRKKLQDVHNF
  • SER-VAL-SER-GLU-ILE-GLN-LEU-MET-HIS-ASN-LEU-GLY-LYS-HIS-LEU-ASN-SER-MET-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-PHE
  • SER-VAL-SER-GLU-ILE-GLN-LEU-MET-HIS-ASN-LEU-GLY-LYS-HIS-LEU-ASN-SER-MET-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-PHE HUMAN
  • Pth(1-34)(human) Acetate
  • Parathormone (1-34)
  • [CYS5,28] PARATHYROID HORMONE (1-34), HUMAN
  • [CYS5,28] PTH (1-34), HUMAN
  • H-SER-VAL-SER-GLU-ILE-GLN-LEU-MET-HIS-ASN-LEU-GLY-LYS-HIS-LEU-ASN-SER-MET-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-PHE-OH
  • Parathyroid Hormone (PTH) (1-34), Human
  • Teroparatide
  • Teriparatide (Forteo)
  • CNV-38d(1-34)
  • Teriparatide, Teriparatida , Teriparatidum
  • Teriparatide (PTH 1-34)
  • PARATHYROID HORMONE FRAGMENT HUMAN 1-34 APPROX. 95%
  • PARATHYROID HORMONE FRAGMENT HUMAN 1-34 90-95%
  • Teriparatide, Parathyroid Hormone(1-34),human
  • parathyroid hormone fragment 1-34 human
  • PARATHYROID HORMONE (PTH) HUMAN 1-34, MIN 95%
  • (1-34)-HUMAN PARATHYROID HORMONE
  • Teriparatide, Parathyroid Hormone(1-34)
  • ALA-VAL-SER-GLU-ILE-GLN-LEU-MET-HIS-ASN-LEU-GLY-LYS-HIS-LEU-ALA-SER-VAL-GLU-ARG-MET-GLN-TRP-LEU-ARG-LYS-LYS-LEU-GLN-ASP-VAL-HIS-ASN-PHE: AVSEIQLMHNLGKHLASVERMQWLRKKLQDVHNF
  • SER-VAL-SER-GLU-CYS-GLN-LEU-MET-HIS-ASN-LEU-GLY-LYS-HIS-LEU-ASN-SER-MET-GLU-ARG-VAL-GLU-TRP-LEU-ARG-LYS-LYS-CYS-GLN-ASP-VAL-HIS-ASN-PHE
  • Teriparatide acetate/HuMan PTH(1-34)
  • M.W. 4117.72 C181H291N55O51S2
  • Parathyroid Hormone Fragment (1-34)
  • H-Ser-Val-Ser-Glu-Ile-Gln-Leu-Met-His-Asn-Leu-Gly-Lys-His-Leu-Asn-Ser-Met-Glu-Arg-Val-Glu-Trp-Leu-Arg-Lys-Lys-Leu-Gln-Asp-Val-His-Asn-Phe-OH acetate salt
  • hPTH (1-34)
  • PTH 1-34;HPTH (1-34);HUMAN PARATHYROID HORMONE-(1-34)
  • Pterospermum heterophyllum Hance.
  • Parathyroid Hormone 1-34, Human - CAS 52232-67-4 - Calbiochem
  • Teriparatide,PTH 1-34,hPTH (1-34),Human parathyroid hormone-(1-34), >99%
  • Teriparatide CRS
  • Teriparatide?Acetate impurity
  • Teriparatide acetate USP/EP/BP
  • Teriparatide,PTH 1-34,hPTH (1-34),Human parathyroid hormone-(1-34)
  • Teriparatide Acetate/pTH(1-34) human
  • Pteris formosana extract
  • Teriparatide D10 AcetateQ: What is Teriparatide D10 Acetate Q: What is the CAS Number of Teriparatide D10 Acetate Q: What is the storage condition of Teriparatide D10 Acetate Q: What are the applications of Teriparatide D10 Acetate
  • TeriparatideAcetateQ: What is TeriparatideAcetate Q: What is the CAS Number of TeriparatideAcetate Q: What is the storage condition of TeriparatideAcetate Q: What are the applications of TeriparatideAcetate
  • Teriparatida(net)
  • pTH (1-34) (human) Acetate(net)
  • Teriparatide (COLD SHIPMENT REQUIRED) (1643962)
  • Teriparatide (Y0001916)
  • Teriparatide for system suitability (Y0001895)
  • leriparatide acetate
  • TeripaRatide Acetate peptide
  • Terliparatide Acetate
  • Teriparatide acetate Powder
  • CNV-38d(1-34),Parathyroid Hormone (1-34), human
  • Parathar
  • Teriparatide Acetate(free base)